News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Metal-Free Carbon Monoxide Prodrugs May Help Prevent Cancer’s Deadly Spread

metastatic cancer cells

Video of CO Podcast Animation

A carefully designed metal-free carbon monoxide prodrug—an inactive compound that is converted into its active form in the body—may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine. The recent preclinical study, published in Advanced Science, offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.

Even after surgery and chemotherapy, microscopic cancer cells may survive and later establish new tumors in distant organs. Researchers have long pursued treatments that can safely block this process.

Dr. Nancy Du

Dr. Nancy Du

An Opportunity to Strengthen Key Health Measures in National Climate Plans

woman holding poster saying climate emergency equals health emergency

The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, found an international team of investigators led by Weill Cornell Medicine.

The study was published on June 10 in Lancet Planetary Health. Senior author Dr. Ilan Cerna-Turoff, assistant professor of epidemiology in emergency medicine at Weill Cornell Medicine, and his study team reviewed climate adaptation policies from 198 countries and the European Union, finding that while 88% mentioned the health impacts of climate change, important gaps in health integration remain. Progress on health integration was variable, with several regions of the world falling behind. Some health conditions were nearly absent. Despite the widespread recognition that specific demographic groups were disproportionately affected by the health impacts of climate change, only 12% of the plans engaged these groups in their efforts. Many plans also lacked sufficient budgeting for monitoring and evaluation and health-related climate actions.

Innovators Pitch Cell Therapies and AI Tools at Biomedical Innovation Challenge

Six people (four men and two women) wearing business attire in a group photo

The eighth cohort of the Biomedical Innovation Challenge showcased its innovations and development plans during a lightning round of pitches and judges’ questions on June 4 in the Belfer Research Building.

The annual event serves as the culmination of BioVenture eLab’s entrepreneurial education program for Weill Cornell faculty and trainees who aspired to take the next step in translating their discoveries into fundable early-stage innovation projects. This year, five teams presented their innovations, as well as their plans to navigate the commercialization journeys ahead to catalyze their research into products aimed at changing patients’ lives.

“Innovation doesn't happen unless scientists and clinicians are willing to learn something new, to think differently and to pursue solutions beyond the current standard of care,” said Loren Busby, director of BioVenture eLab, noting how this latest class had evolved from researchers into entrepreneurs after completing the program. “This is the definition of entrepreneurship on which we rely in our program.”